Conjugate of liver cancer specifically targeted peptide A54 and amycin and coupling method and application thereof
The invention discloses a conjugate of liver cancer specifically targeted peptide A54 and amycin, wherein the structural formula of the conjugate is a structural formula (1) or (2) as shown in the specification, the amino acid sequence of the liver cancer specifically targeted peptide A54 is NH2-AGK...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a conjugate of liver cancer specifically targeted peptide A54 and amycin, wherein the structural formula of the conjugate is a structural formula (1) or (2) as shown in the specification, the amino acid sequence of the liver cancer specifically targeted peptide A54 is NH2-AGKGTPSLETTP-COOH; the amycin is chemically coupled with the terminal carboxyl group and/or the interposition carboxyl group of the liver cancer specifically targeted peptide A54; and the interposition carboxyl group is the carboxyl group on glutamic acid (E) in the sequence of the liver cancer specifically targeted peptide A54. The invention also discloses a chemical coupling method for preparing the conjugate, and application of the conjugate in preparing a medicament for treating liver cancer. |
---|